Epidemiology and Management of Metastatic Breast Cancer

Epidemiology and Therapeutic Management of Metastatic Breast Cancer in Romania: A Retrospective Cohort Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01711502

Enrollment

128

Registered

2012-10-22

Start date

2013-01-31

Completion date

2013-06-30

Last updated

2014-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Nos Metastatic Recurrent

Keywords

metastatic breast cancer,, epidemiology,, retrospective cohort

Brief summary

This is a multicenter, national, retrospective chart-review study that will be based on the collection of data from electronical or paper-based medical records with available data on female patients diagnosed with metastatic brest cancer . The main purpose of this study is to provide accurate, evidence based description on the incidence of progression of metastatic breast cancer and its clinical management.

Detailed description

Epidemiology and Therapeutic Management of Metastatic Breast Cancer in Romania: A retrospective cohort study

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Female aged 18 years and over Diagnosis of breast cancer according to ICD-10 diagnostic criteria with confirmed metastasis * Confirmed diagnosis between 1st July 2010 - 30th June 2011 * Female patient managed for her disease at the same setting where final diagnosis of MBC was performed

Exclusion criteria

* History of concurrent or other primary malignancies (except curatively resected non-melanoma skin cancer or in situ cervical cancer)

Design outcomes

Primary

Measure	Time frame
The incidence rate of progression of disease in a cohort of patients newly diagnosed with MBC, either De Novo or having progressed from a non-metastatic stage	At 12 and 18 months after diagnosis

Secondary

Measure	Time frame
The progression free survival (PFS) time	At 18 months after diagnosis
Time to progression (TTP)	At 18 months after diagnosis
The clinical and pathological characteristics of newly diagnosed MBC patients	At 18 months after diagnosis
The socio-demographic and anthropometric characteristics of newly diagnosed MBC patients	At 18 months after diagnosis
Health care utilization associated with the disease in Romania	At 18 months after diagnosis
The progression free survival (PFS) rates	At 12 and 18 months after diagnosis

Countries

Romania

Outcome results